Our focus is where immunology research meets unmet medical need. Efgartigimod, a potentially first-in-class investigational antibody fragment is being studied across several autoimmune diseases and we’re exploring additional product candidates. Discover the breadth and depth of our pipeline.
Bleiben Sie auf dem neuesten Stand
Erhalten Sie Neuigkeiten und Updates von argenx direkt in Ihren Posteingang
Get photos, fact sheets, illustrations and more.
Join the team
Dare to do more with a thriving career at Argenx.
Get the latest news and info via our social media channels.